1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next >>

Ahead of Global Layoffs, Ranbaxy Touts Quality/Compliance Changes [499 Words] 05/22/2013

Compounding Regulation Bill to Senate Floor [414 Words] 05/22/2013

Companies Back Proposed Rodent Testing Change [265 Words] 05/22/2013

Stakeholders Support Benefit-Risk Assessment Approach [314 Words] 05/22/2013

FDA Panel Backs Merck’s Low-dose Insomnia Drug [248 Words] 05/22/2013

CDER ’Good Email Practices’ Go Into Effect at Month End [242 Words] 05/22/2013

Public Meeting On Standardizing REMS [125 Words] 05/22/2013

FDA Science Board to Meet [118 Words] 05/22/2013

FDA Accepts Upsher-Smith NDA for Epilepsy [103 Words] 05/22/2013

FDA Questions uChek Urine Analyzer Clearance [150 Words] 05/22/2013

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  Next >>